Alzheimer’s disease in Taiwan: registration and prevalence-Reference-Cited by-同舟云学术

Alzheimer’s disease in Taiwan: registration and prevalence

Published:2013-06 Issue:3 Volume:3 Page:195-197
ISSN:1758-2024
Container-title:Neurodegenerative Disease Management
language:en
Short-container-title:Neurodegenerative Disease Management

Author:

Yang Yuan-Han¹

Affiliation:

1. Department of & Master’s Program in Neurology, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan; Department of Neurology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; and Mentality Protection Center, FoGuang Shan Compassion Foundation, Taiwan.

Publisher

Future Medicine Ltd

Subject

Neurology (clinical)

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nmt.13.24

Reference12 articles.

1. The global prevalence of dementia: A systematic review and metaanalysis

2. The worldwide economic impact of dementia 2010

3. Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey

4. Prevalence and Subtypes of Dementia in Taiwan: A community Survey of 5297 Individuals

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer’s Disease in Taiwan;Advances in Therapy;2019-04-05

2. Qifu-Yin attenuates AGEs-induced Alzheimer-like pathophysiological changes through the RAGE/NF-κB pathway;Chinese Journal of Natural Medicines;2014-12